ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc (APLS)

17.62
0.00
(0.00%)
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 94.97M110.4M146.38M172.33M199.68M196.83M212.53M166.8M
Operating Income -120.44M-137.08M-84.52M-62.09M-29.44M-47.28M-26.16M-83.33M
Pre Tax Income -121.84M-140M-84.15M-66.25M-37.54M-56.85M-36.07M-91.88M
Net Income -122.04M-140.24M-85.58M-66.42M-37.66M-57.45M-36.35M-92.23M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -120.51M-137.68M-84.3M-62.59M-29.42M-47.21M-27.93M-83.49M
EBITDA -120.02M-136.62M-84.04M-61.65M-29M-46.82M-25.72M-82.88M
Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000250.65M66.56M75.42M396.59M781.37M
Operating Income -50.77M-127.93M-288.02M-213.73M-536.28M-594.61M-517.12M-164.98M
Pre Tax Income -51.01M-127.5M-304.71M-343.03M-746M-651.5M-523.5M-196.72M
Net Income -51.01M-127.5M-304.71M-344.87M-746.35M-652.17M-525.63M-197.88M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.013-2.266-5.414-4.53-7.653-5.888-4.436-1.591
EBIT -50.76M-128.04M-289.69M-214.23M-534.92M-594.9M-517.85M-167.15M
EBITDA -50.77M-127.93M-287.78M-213.09M-534.9M-593.06M-515.34M-163.18M

Your Recent History

Delayed Upgrade Clock